文献速递中医内科中药与中成药合理使用

心音片经HDAC3介导PINK1/Parkin通路调控线粒体自噬与心肌凋亡改善慢性心衰

Xinyin tablets affect mitophagy and cardiomyocyte apoptosis to alleviate chronic heart failure by regulating histone deacetylase 3(HDAC3)-mediated PTEN induced putative kinase 1(PINK1)/Parkin signaling pathway.
PubMed 文献 · J Ethnopharmacol · 2025-03-21

该研究在C57小鼠冠脉结扎慢性心衰模型和H9c2缺氧心肌细胞中,观察心音片对心功能、线粒体自噬及心肌凋亡的影响。结果表明心音片可改善小鼠心脏功能指标并下调caspase-3、caspase-9、Bax表达,同时上调PINK1、Parkin表达;其作用与HDAC3介导的PINK1/Parkin信号通路调控线粒体自噬、抑制心肌凋亡相关。

要点

  • 心音片可改善慢性心衰小鼠LVEF、LVFS、LVEDD、LVESD、LVESV等心脏功能指标。
  • 心音片下调心肌caspase-3、caspase-9、Bax表达并上调PINK1、Parkin表达。
  • 机制涉及HDAC3介导的PINK1/Parkin通路调控线粒体自噬与心肌凋亡。

核心结论

  • 心音片可能通过HDAC3介导的PINK1/Parkin信号通路改善线粒体自噬并抑制心肌细胞凋亡,从而干预慢性心衰。

研究设计与样本

  • 体内实验将60只SPF C57小鼠随机分为6组:假手术组、模型组、心音片低中高剂量组和培哚普利组,除假手术组外均行冠状动脉结扎,药物干预4周。
  • 体外实验以缺氧H9c2心肌细胞为对象,给予不同浓度心音片及含药血清处理,并使用雷帕霉素、Mdivi-1、ITSA-1、RGFP966设置干预条件。
  • 采用LC-MS/MS鉴定心音片化学成分,采用超声心动图、HE染色、Masson三色染色、RT-qPCR、Western blotting、TUNEL染色和透射电镜进行检测。

主要发现

  • 从心音片中表征出785种化合物,其中碳水化合物和糖苷、苯丙素类、萜类含量丰富,并存在少量氨基酸、肽及其衍生物。
  • 体内实验中心音片改善心脏功能(LVEF、LVFS、LVEDD、LVESD、LVESV),下调caspase-3、caspase-9、Bax表达,并上调PINK1、Parkin表达。
  • 体外实验在H9c2心肌细胞中强化了上述发现;雷帕霉素和RGFP966减少缺氧H9C2心肌细胞凋亡并增加HDAC3介导的PINK1/Parkin通路介导的线粒体自噬。

临床怎么用

  • 心音片作为已用于慢性心衰临床防治的中成药,本研究的动物与细胞实验为其改善心功能及调控线粒体自噬—凋亡通路的潜在机制提供了依据。
  • 研究中采用培哚普利作为阳性对照,提示心音片在慢性心衰模型中的效应可与该对照药物在同一实验框架下比较。

局限性

  • 研究仅在SPF C57小鼠和H9c2细胞中进行,尚未提供临床人群的有效性与安全性数据。
  • 心音片成分复杂,785种化合物中具体发挥HDAC3/PINK1/Parkin通路调控作用的活性成分尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Xinyin tablets, Chinese patent medicine, are composed of Panax ginseng C.A.Mey. (Araliaceae), Ilex pubescens Hook. & Arn. (Aquifoliaceae), Leonurus japonicus Houtt. (Lamiaceae), Plantago asiatica L. (Plantaginaceae), Ophiopogon japonicus (Thunb.) Ker Gawl. (Asparagaceae), Astragalus membranaceus (Fisch.) Bunge, and Draba nemorosa L. (Brassicaceae). It has been used for the prevention and treatment of chronic heart failure (CHF) clinically. However, its underlying mechanism of action is far from completely understood. AIM OF THE STUDY: This study aimed to determine whether Xinyin tablets alleviate CHF in SPF C57 mice and to explore the potential mechanism of action in H9c2 cells. MATERIALS AND METHODS: Liquid chromatography tandem mass spectroscopy (LC-MS/MS) was performed to identify the chemical compounds in Xinyin tablets. In vivo, 60 C57 mice were randomly divided into 6 groups: the sham group; model group; low-, medium-, and high-dose Xinyin tablets groups; and perindopril group. Animals in the sham group underwent thoracotomy only. The others were subjected to coronary artery ligation. After 4 weeks of drug intervention, the cardiac function of the mice in each group was detected via echocardiography, the myocardial cells were evaluated via HE staining, and the degree of myocardial fibrosis was detected via Masson's trichrome staining. The expression of PINK1/Parkin signaling pathway-related genes (HDAC3, PINK1, Parkin, P62, LC3II/I, caspase-3, caspase-9, and Bax) was analyzed via RT‒qPCR and Western blotting. The effects of Xinyin tablets on cardiomyocyte apoptosis and mitophagy mediated by the HDAC3 and PINK1/Parkin pathways in CHF model mice were evaluated. In vitro, H9c2 cardiomyocytes subjected to hypoxia were treated with different concentrations of Xinyin tablets. The mRNA transcription levels of HDAC3, PINK1, Parkin, P62, LC3II/I, caspase-3, caspase-9, and Bax were measured via fluorescence quantitative PCR. Western blotting was used to detect the protein expression levels of PINK1, Parkin, P62, LC3 II/I, caspase-3, caspase-9, and Bax. TUNEL staining was used to detect the number of apoptotic bodies in the myocardium to evaluate the level of apoptosis. Transmission electron microscopy was used to observe changes in the number of mitophagosomes. Rapamycin (mitophagy agonist), Mdivi-1 (mitophagy inhibitor), ITSA-1 (HDAC3 agonist) and RGFP966 (HDAC3 inhibitor) were used to create intervention conditions. The effects of rapamycin or Mdivi-1 on PINK1/Parkin-mediated mitophagy were observed. Then, the effects of HDAC3 on the PINK1/Parkin signaling pathway, mitophagy and apoptosis in hypoxic cardiomyocytes were observed. Hypoxic cardiomyocytes were treated with Xinyin tablets-containing serum or control serum to observe whether Xinyin tablets could still play a protective role in cardiomyocytes when HDAC3 is activated or mitophagy is inhibited. RESULTS: 785 compounds were characterized from Xinyin tablets, among which carbohydrates and glycosides, phenylpropanoids, terpenes were abundant, and a small number of amino acids, peptides and derivatives also existed in Xinyin tablets. In vivo, Xinyin tablets improved cardiac function (LVEF, LVFS, LVEDD, LVESD, and LVESV) and downregulated the expression of caspase-3, caspase-9, and Bax. The expression levels of PINK1 and Parkin subsequently increased. In vitro, the above findings were reinforced in H9c2 cardiomyocytes. Rapamycin and RGFP966 reduced the apoptosis of hypoxic H9C2 cardiomyocytes and increased mitophagy mediated by the HDAC3-mediated PINK1/Parkin signaling pathway. CONCLUSIONS: Xinyin tablets have potential as an intervention for CHF by improving mitophagy and inhibiting cardiomyocyte apoptosis through the HDAC3-mediated PINK1/Parkin signaling pathway.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Chen H, Lin Q, Zeng Y, et al. Xinyin tablets affect mitophagy and cardiomyocyte apoptosis to alleviate chronic heart failure by regulating histone deacetylase 3(HDAC3)-mediated PTEN induced putative kinase 1(PINK1)/Parkin signaling pathway. J Ethnopharmacol. 2025. PMID: 40122315. doi:10.1016/j.jep.2025.119666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。